How to buy Motus GI stock | $1.02

Motus GI Holdings, Inc is a diagnostics & research business based in the US. Motus GI shares (MOTS) are listed on the NASDAQ and all prices are listed in US Dollars. Motus GI employs 24 staff and has a trailing 12-month revenue of around 0.00.

Motus GI stock price (NASDAQ: MOTS)

Use our graph to track the performance of MOTS stocks over time.

Motus GI shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$1.02
52-week range	$0.68 - $2.30
50-day moving average	$1.03
200-day moving average	$1.24
Wall St. target price	$2.24
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.21

Buy Motus GI shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Motus GI stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Motus GI Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Motus GI price performance over time

Historical closes compared with the close of $1.02 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	1.02
3 months (2021-04-30)	-26.62%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

Motus GI financials

Revenue TTM	$121,000
Gross profit TTM	$-398,000
Return on assets TTM	-35.85%
Return on equity TTM	-108.56%
Profit margin	0%
Book value	$0.42
Market capitalisation	$44 million

TTM: trailing 12 months

Shorting Motus GI shares

There are currently 3.7 million Motus GI shares held short by investors – that's known as Motus GI's "short interest". This figure is 1.2% up from 3.7 million last month.

There are a few different ways that this level of interest in shorting Motus GI shares can be evaluated.

Motus GI's "short interest ratio" (SIR)

Motus GI's "short interest ratio" (SIR) is the quantity of Motus GI shares currently shorted divided by the average quantity of Motus GI shares traded daily (recently around 444180.61831153). Motus GI's SIR currently stands at 8.41. In other words for every 100,000 Motus GI shares traded daily on the market, roughly 8410 shares are currently held short.

However Motus GI's short interest can also be evaluated against the total number of Motus GI shares, or, against the total number of tradable Motus GI shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Motus GI's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Motus GI shares in existence, roughly 80 shares are currently held short) or 0.0925% of the tradable shares (for every 100,000 tradable Motus GI shares, roughly 93 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Motus GI.

Find out more about how you can short Motus GI stock.

Motus GI share dividends

We're not expecting Motus GI to pay a dividend over the next 12 months.

Motus GI share price volatility

Over the last 12 months, Motus GI's shares have ranged in value from as little as $0.68 up to $2.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Motus GI's is 2.6211. This would suggest that Motus GI's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Motus GI overview

Motus GI Holdings, Inc. , a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida. .

Frequently asked questions

What percentage of Motus GI is owned by insiders or institutions?
Currently 7.428% of Motus GI shares are held by insiders and 16.129% by institutions. How many people work for Motus GI?
Latest data suggests 24 work at Motus GI. When does the fiscal year end for Motus GI?
Motus GI's fiscal year ends in December. Where is Motus GI based?
Motus GI's address is: 1301 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301 What is Motus GI's ISIN number?
Motus GI's international securities identification number is: US62014P1084 What is Motus GI's CUSIP number?
Motus GI's Committee on Uniform Securities Identification Procedures number is: 62014P108